Tag Archives: Benefits
Posted on02. Sep, 2015 by Admin.
10. Treatment of Glaucoma
If you are one of the millions who have been suffering from glaucoma, then smoking marijuana can help you get the best eyesight and relieve pressure from they eyes. Intraocular pressure can increase in certain individuals, especially those who have diabetes. Glaucoma is serious disease that can cause blindness.
9. Manage Epileptic Seizures
People who suffer from epileptic disorders or seizures can get tremendous relief and relaxation from smoking marijuana.
8. Pain Reliever
Marijuana ingestion can benefit your health when used to lessen the pain of MS, Rheumatoid arthritis and migraines. Also those sufferers of HIV, amputation, alcoholism and spinal surgery who are experiencing nerve pain seem to have a lessening of their pain when they are on a medical marijuana treatment protocol.
Marijuana, in the 2010 Canadian study, was found in these patients to be many more times more effective then aspirin in limiting their perception of pain. Medicinal marijuana is administered in more controlled dosages, and strengths that is found on the street. It is a stated goal of physicians to “do no harm.” The lessening of a patient’s pain, represents the epitome of this goal.
7. Prevents the Spread of Cancer
There is a chemical found in marijuana that has been shown to inhibit the growth of cancer cells. Researchers believe the process is that cannabidiol turns off the Id-1 gene. Cancer cells duplicate this gene in higher numbers than non-cancerous cells.
Researchers also studied breast cancer cells in the lab that contained Id-1 in high quantities. They were treated with cannibidiol. The result of this treatment was a lower incidence of Id-1 and the remaining genes were found to be less invasive.
There have been studies done in the US, Spain and Israel that posit that chemicals in marijuana can actually mean the death of cancer cells.
6. THC Reduces the Growth of Alzheimer’s
THC can help to slow down the progression of Alzheimer’s disease. A study from 2006 found that chemicals in this drug can help keep amyloid plaques from forming. This will help keep you from getting this disease, and legalizing this drug could have everything to do with finding a cure.
5. Reduces the Spread of HIV
Cannabis is highly regarded in the medical community for it’s effectiveness in treating patients with HIV. People who have contracted the disease suffer from weight loss and body aches amongst other many things however, a new research that suggest cannabis might be able to halt the spread of the disease altogether has come to light. Additionally, a study was conducted in Louisiana; in this research scientists gave a daily dose of THC to primates who had contracted an animal form of the HIV. Over the course of the study, scientists found that the damage to immune system in the primates’ stomach had decreased.
4. Relieves Arthritis Pain
Marijuana will help with rheumatoid arthritis pain, swelling and allow them to have restful sleep .According to a 2011 study, where a cannabis based pain killer was given to rheumatoid arthritic patients, there was a marked decrease in observable pain, compared to the administration of a placebo.
Rheumatoid arthritis can be an extremely debilitating disease, striking the joints of the affected patients. The subsequent swelling causes a reduction in the range of motion. But this kind of arthritis is different than osteoarthritis, the kind one gets with old age. RA is an autoimmune disease, meaning in effect your body is attacking healthy cells. Any age group can get it, and any gender, but women are stricken the most.
3. Slows Metabolism, Helps with Weight Loss
Another use for medicinal marijuana is stimulating appetite. Recent studies by the National Cancer Institute indicate that the inhalation of cannabis can lead to an increased consumption of calories. Conversely, studies published in the American Journal of Medicine suggested that pot smokers are skinnier than the average person. They studied their levels of the hormone insulin and their blood sugar levels, and even though marijuana users consume more calories, they tend to have a healthier metabolism and a better reaction to sugars. The study analyzed data from more than 4,500 adult Americans – 579 of whom were current marijuana smokers, meaning they had smoked in the last month. About 2,000 had used marijuana in the past, while another 2,000 had never used the drug.
2. Calms Tremors in Parkinson’s Patients
Research has shown for patients suffering from the debilitating disease Parkinson, smoking pot can help reduce pain and tremors. It has been show to increase sleep quality as well as improving fine motor skills. Much of this research has been conducted in Israel.
Being able to release muscle tension, is another benefit of medical marijuana. A study done by the American Cancer Society shows that patients suffering from multiple sclerosis (MS), who used a liquid form of cannabis, encountered a reduced in muscle spasms as well shaking.
Another study done on eight MS patients, in advanced stages, showed a reduction in tremors and muscle stiffness.
1. Helps Veterans Afflicted with PTSD
Marijuana is a safer and less harmful alternative to traditional PTSD treatment. The relaxing effect marijuana has on the user without the fuzzy mental state caused by antidepressants can allow soldiers to relieve their anxiety without having to feel medicated. Antidepressants and other drugs prescribed for PTSD possess a high risk for addiction and are not recommended for use over long periods of time. Marijuana use can fluctuate, wane, or increase depending on the state of the patient with little no side effects based upon the amount of usage. There are no conclusive studies that indicate marijuana is addicting in the traditional sense of drug addiction such as substances with opiates. Marijuana may be the safest anti depressant on the market.
News Moderator: Jacob Redmond 420 MAGAZINE ®
Full Article: Ten Health Benefits of Marijuana
Author: Marc Howard
Photo Credit: MGN News
Website: Institute for Ethics and Emerging Technologies
Posted on20. Dec, 2013 by Admin.
Following the Wednesday release of a national survey on teen drug use, sponsored by the National Institute on Drug Abuse (NIDA), the Marijuana Policy Project (MPP) called on the agency to investigate whether regulating marijuana like alcohol and cigarettes could produce similar reductions in use among teens.
According to the annual Monitoring the Future national survey on drug use, the current use of alcohol and tobacco has dropped among teens in the 8th, 10th, and 12th grades. Current marijuana use increased slightly among 8th- and 10th-graders and decreased slightly among 12th-graders. Current use is defined as use within the past 30 days.
“The results suggest that regulating alcohol and cigarettes is successfully reducing teen use, whereas marijuana prohibition has been unsuccessful,” said MPP director of communications Mason Tvert. “At the very least, this data should inspire NIDA to examine the possibility that regulating marijuana like alcohol and cigarettes could be a more effective approach than the current system.”
Yesterday, MPP issued a release based on a preliminary summary of the survey results, in which it announced its expectation that marijuana use had not increased among teens. The full survey results show that marijuana use within thirty days of the survey has increased from 6.5% to 7% among 8th-graders and from 17% to 18% among 10th-graders. It has decreased from 22.9% to 22.7% among 12th-graders. Current alcohol use has decreased from 11% to 10.2% among 8th-graders, from 27.6% to 25.7% among 10th-graders, and from 41.5% to 39.2% among 12th-graders. Cigarette use in the past thirty days decreased from 4.9% to 4.5% among 8th-graders, from 10.8% to 9.1% among 10th-graders, and from 17.1% to 16.3% among 12th-graders.
“Those selling marijuana in the underground market are not asking for ID,” Tvert said. “By regulating marijuana like alcohol and cigarettes and enforcing similar age restrictions, we would very likely see a similar decrease in availability and use among teens.”
Colorado’s experience with regulating medical marijuana suggests that regulation might be reducing teen use. According to the Youth Risk Behavior Surveillance System survey released in June 2012 by the U.S. Centers for Disease Control and Prevention, marijuana use by Colorado high school students dropped 11% from 2009 to 2011, the time period in which the state and its localities began regulating medical marijuana. Nationwide, teen marijuana use increased 11% during that time period.
Posted on22. May, 2013 by Admin.
Brain imaging research published this month in the journal Molecular Psychiatry provides physiological evidence as to why cannabis may mitigate certain symptoms of post-traumatic stress disorder (PTSD)
Post-traumatic stress syndrome is an anxiety disorder that is estimated to impact some eight million Americans annually. Yet, to date, there are no pharmaceutical treatments specifically designed or approved to target symptoms of PTSD.
Investigators at the New York University School of Medicine and the New York University Langone Medical Center, Steven and Alexandra Cohen Veterans Center for the Study of Post-Traumatic Stress and Traumatic Brain Injury reported that subjects diagnosed with PTSD typically possess elevated quantities of endogenous cannabinoid receptors in regions of the brain associated with fear and anxiety. Investigators also determined that many of these subjects experience a decrease in their natural production of anandamide, an endogenous cannabinoid neurotransmitter, resulting in an imbalanced endocannibinoid regulatory system.
Researchers speculated that an increase in the body’s production of cannabinoids would likely restore subjects’ natural brain chemistry and psychological balance. They affirmed, “[Our] findings substantiate, at least in part, emerging evidence that … plant-derived cannabinoids such as marijuana may possess some benefits in individuals with PTSD by helping relieve haunting nightmares and other symptoms of PTSD.”
They concluded: “The data reported herein are the first of which we are aware of to demonstrate the critical role of CB1 (cannabinoid) receptors and endocannabinoids in the etiology of PTSD in humans. As such, they provide a foundation upon which to develop and validate informative biomarkers of PTSD vulnerability, as well as to guide the rational development of the next generation of evidence-based treatments for PTSD.”
Anecdotal evidence and case study reports have increasingly indicated that cannabis may mitigate traumatic memories and anxiety. However, clinical trial data remains unavailable, in large part because US federal officials have blocked investigators’ efforts to study cannabis in PTSD subjects. In 2011 federal administrators halted efforts by investigators at the University of Arizona to complete an FDA-approved, placebo-controlled clinical trial to evaluate the use of cannabis in 50 veterans with treatment-resistant PTSD.
PTSD is also seldom identified as a qualifying condition in states that allow for the physician authorized use of cannabis therapy. (To date, only New Mexico explicitly cites PTSD as a qualifying condition for cannabis treatment, although a handful of other states, like California, allow doctors the discretion to legally recommend marijuana for post-trauma subjects.) In Oregon, lawmakers in the House are considering Senate-approved legislation, SB 281, that would allow PTSD patients to legally consume cannabis under the state’s nearly 15-year-old medical marijuana program.
Posted on11. Apr, 2013 by Admin.
Thousands of medical marijuana patients in the United States rely on the drug to alleviate a multitude of symptoms from cachexia to nerve pain; nevertheless, the Drug Enforcement Administration (DEA) still considers it a Schedule I controlled substance that has no accepted medical use.
Despite this law-enforcement-agency-approved “analysis,” doctors are conducting their own research. In Israel, the Meir Medical Center is recruiting Crohn’s Disease sufferers for a study on the ability of marijuana to treat the inflammatory bowel disease, which affects 400,000-600,000 North Americans.
In San Francisco, for more than five years, doctors at California Pacific Medical Center have been studying the effects of the marijuana compound cannabidiol (CBD) on metastatic cancer cells (i.e., very aggressive tumor cells). In their recently published large-scale animal trial, brain scans revealed the disruption of tumor cells after CBD was used to switch off a specific gene regulator.
These promising results left researchers optimistic and they believe that the findings warrant human trials. They will work to secure funding in the upcoming months for two trial groups, one for brain cancer and the other for breast cancer.
Will these and other studies finally convince our government that science, not myth, should dictate how we approach marijuana?